Nasr, L. F., Goulart, H., Short, N. J., Jain, N., Zhao, M., Kadia, T. M., DiNardo, C. D., Daver, N. G., Pemmaraju, N., Ferrajoli, A., Bataller, A., Haddad, F., Senapati, J., Hachem, M., Garcia-Manero, G., Garris, R. S., Ravandi-Kashani, F., Kantarjian, H. M., Jabbour, E. (2026). Long-term outcomes with addition of inotuzumab ozogamicin to HCVAD and sequential blinatumomab in adults with newly diagnosed B-ALL.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.6515